Regulus Therapeutics Inc Cash Flow-to-Debt Ratio
Regulus Therapeutics Inc cash flow-to-debt ratio. Regulus Therapeutics Inc (RGLS) has a Cash Flow-to-Debt Ratio of -1.83x as of March 2025, meaning its operating cash flow of $-10.61 Million could theoretically repay -2% of its total liabilities ($5.80 Million) in one year. See RGLS FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Regulus Therapeutics Inc (2010–2024)
Cash flow-to-debt ratio of Regulus Therapeutics Inc from 2010 to 2024. Historical debt coverage capacity for Regulus Therapeutics Inc across 15 annual periods. Check how aggressively does Regulus Therapeutics Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Regulus Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2010–2024)
Regulus Therapeutics Inc cash flow-to-debt ratio by year from 2010 to 2024. Year-by-year debt coverage analysis for Regulus Therapeutics Inc. For the full cash flow conversion analysis, see Regulus Therapeutics Inc cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -5.36x | $-41.67 Million | $7.77 Million | ▼ -91.5% |
| 2023 | -2.80x | $-26.77 Million | $9.56 Million | ▼ -47.2% |
| 2022 | -1.90x | $-25.53 Million | $13.43 Million | ▼ -6.4% |
| 2021 | -1.79x | $-24.13 Million | $13.50 Million | ▼ -65.1% |
| 2020 | -1.08x | $-12.54 Million | $11.58 Million | ▼ -20.5% |
| 2019 | -0.90x | $-19.82 Million | $22.07 Million | ▲ +29.9% |
| 2018 | -1.28x | $-43.27 Million | $33.78 Million | ▲ +7.2% |
| 2017 | -1.38x | $-58.77 Million | $42.59 Million | ▼ -8.2% |
| 2016 | -1.28x | $-56.88 Million | $44.59 Million | ▲ +56.5% |
| 2015 | -2.93x | $-49.86 Million | $17.00 Million | ▼ -192.9% |
| 2014 | -1.00x | $-39.51 Million | $39.47 Million | ▼ -4.6% |
| 2013 | -0.96x | $-28.33 Million | $29.61 Million | ▼ -354.5% |
| 2012 | -0.21x | $-8.72 Million | $41.42 Million | ▼ -17.9% |
| 2011 | -0.18x | $-15.06 Million | $84.38 Million | ▼ -175.0% |
| 2010 | 0.24x | $12.31 Million | $51.71 Million | — |